Onyx Biotec Limited — Others, 09-04-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Onyx Biotec Ltd. has announced a board meeting concerning its non-applicability of corporate governance provisions as outlined in SEBI regulations. The company qualifies for exemption due to its paid-up equity share capital not exceeding ₹10 Cr and net worth below ₹25 Cr, following its listing on NSE EMERGE. This status for the quarter ended March 31, 2025, could streamline operations and reduce compliance costs. Investors may view this as a neutral impact, presenting a clearer regulatory landscape, while potential risks related to governance standards still remain.